Alpha 2.0
Login Register
» Articles » PMID: 29793646

Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria

Overview
Journal J Thorac Oncol
Publisher Elsevier
Specialties Oncology
Pulmonary Medicine
Date 2018 May 26
PMID 29793646
Citations 7
Authors
Philip Bonomi
Gideon Blumenthal
Andrea Stern Ferris
David J Stewart
Wendy K D Selig
Lee M Krug
Jeff Allen
Gwynn Ison
Corey J Langer
Allen Melemed
Lauretta Odogwu
Upal Basu Roy
Alan Sandler
Affiliations
Soon will be listed here.
Citing Articles

Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center.

Dehar N, Meem M, Aggarwal I, Hopman W, Gaudreau P, Robinson A JTO Clin Res Rep. 2024; 5(7):100696.

PMID: 39091596 PMC: 11293570. DOI: 10.1016/j.jtocrr.2024.100696.

New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.

Stewart D, Bradford J, Sehdev S, Ramsay T, Navani V, Rawson N Curr Oncol. 2024; 31(5):2453-2480.

PMID: 38785465 PMC: 11119944. DOI: 10.3390/curroncol31050184.

Improving the performance status in advanced non-small cell lung cancer patients with chemotherapy (ImPACt trial): a phase 2 study.

Pathak N, Garg R, Khurana S, Kumar S, Kumar A, Pushpam D J Cancer Res Clin Oncol. 2023; 149(9):6399-6409.

PMID: 36759393 DOI: 10.1007/s00432-023-04617-1.

A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility Criteria.

Gerber D, Singh H, Larkins E, Ferris A, Forde P, Selig W JAMA Oncol. 2022; 8(9):1333-1339.

PMID: 35925576 PMC: 9934063. DOI: 10.1001/jamaoncol.2022.1664.

The need for speed in advanced non-small cell lung cancer: A population kinetics assessment.

Stewart D, Maziak D, Moore S, Brule S, Gomes M, Sekhon H Cancer Med. 2021; 10(24):9040-9046.

PMID: 34766461 PMC: 8683556. DOI: 10.1002/cam4.4411.